Eledon Pharmaceuticals(ELDN) - 2024 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36620 ELEDON PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 20-1000967 (State or other jurisdiction of incorporation or organization) 19800 MacArthur Blvd., Suite 250 Irvine, California 92612 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SEC ...